trending Market Intelligence /marketintelligence/en/news-insights/trending/fNViiYlk4fHNRRf5sHvqOw2 content esgSubNav
In This List

Grifols gets US FDA green light for blood testing system

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Grifols gets US FDA green light for blood testing system

Grifols SA obtained approval from the U.S. Food and Drug Administration for Erytra Eflexis, its benchtop analyzer for blood testing.

The system uses Grifols' DG Gel technology to ensure that the blood of a transfusion recipient and the donor are compatible.

Erytra Eflexis, which received the European Commission's CE Mark in June 2017, can be used as a stand-alone system or in combination with other Grifols blood typing portfolio solutions, the Spanish healthcare company said.